AbCellera Biologics

ABCL

NASDAQHealth Care

Income Statement

Total Revenue$28.83M

Gross Profit$28.83M

Operating Income$-314.77M

EBITDA$-103.4M

EBIT$-200.4M

Pre-tax Income$-177.6M

Net Income$-162.86M

Cash Equivalent$163.71M

Total Debt$65.39M

Book Value$1.09B

Book Value Per Share3.72

Return on Equity (ROE)-15.42%

Return on Assets (ROA)-11.97%

Return on Invested Capital (ROI)-15.42%

Net Profit Margin-564.83%

Current Ratio9.81

Quick Ratio9.69

Long-Term Debt / Equity0.00